Back to search
Raynaud Phenomenon Secondary to Systemic Sclerosis
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Raynaud Phenomenon Secondary to Systemic Sclerosis trials may be worth asking aboutClinical trial pipeline · Data from ClinicalTrials.gov
See which Raynaud Phenomenon Secondary to Systemic Sclerosis trials may be worth asking aboutNorth America
Europe
Asia-Pacific
Rest of World
Trials may have sites in multiple countries. Filtering shows any trial with at least one site in the selected country.
The primary objective of the study is to determine the activity of selexipag on Raynaud attack frequency in subjects with Raynaud's Phenomenon (RP) secondary to…
This is a Phase 3, multicenter, double-blind, randomized, placebo-controlled study to evaluate the safety and efficacy of iloprost on the frequency of and relie…